Recombinant Mouse TNFSF11/RANKL/CD254 Protein (With Carrier), Human

Artikelnummer: ABB-RP02134C
Artikelname: Recombinant Mouse TNFSF11/RANKL/CD254 Protein (With Carrier), Human
Artikelnummer: ABB-RP02134C
Hersteller Artikelnummer: RP02134C
Alternativnummer: ABB-RP02134C-20UG, ABB-RP02134C-10UG, ABB-RP02134C-100UG
Hersteller: ABclonal
Wirt: Human
Kategorie: Proteine/Peptide
Spezies Reaktivität: Mouse
Immunogen: Arg72-Asp316
Alternative Synonym: ODF, OPGL, RANKL, Ly109l, Trance, TNFSF11,Tumor necrosis factor ligand superfamily member 11
Tumor necrosis factor ligand superfamily member 11, also known as Receptor activator of nuclear factor kappa-B ligand, Osteoprotegerin ligand, TNFSF11, RANKL, TRANCE, OPGL and CD254, is a single-pass type II membrane protein that belongs to the tumor necrosis factor family. The receptor activator of nuclear factor-kappaB ligand (RANKL), its cognate receptor RANK, and its natural decoy receptor osteoprotegerin have been identified as the final effector molecules of osteoclastic bone resorption. RANK and RANKL are key regulators of bone remodeling and regulate T cell/dendritic cell communications, and lymph node formation. Moreover, RANKL and RANK are expressed in mammary gland epithelial cells and control the development of a lactating mammary gland during pregnancy. Genetically, RANKL and RANK are essential for the development and activation of osteoclasts and bone loss in response to virtually all triggers tested. Inhibition of RANKL function via the natural decoy receptor osteoprotegerin (OPG, TNFRSF11B) prevents bone loss in postmenopausal osteoporosis and cancer metastases. Importantly, RANKL appears to be the pathogenetic principle that causes bone and cartilage destruction in arthritis. RANK-RANKL signaling not only activates a variety of downstream signaling pathways required for osteoclast development, but crosstalk with other signaling pathways also fine-tunes bone homeostasis both in normal physiology and disease. In addition, RANKL and RANK have essential roles in lymph node formation, establishment of the thymic microenvironment, and development of a lactating mammary gland during pregnancy.
Konzentration: < 0.01 EU/µg of the protein by LAL method.
Molekulargewicht: 55.63 KD
NCBI: 21943
UniProt: O35235
Formulierung: Lyophilized from a 0.22 µm filtered solution of PBS, pH 7.4 with 50 µg BSA per 1 µg as a carrier protein.
Target-Kategorie: Tnfsf11, Opgl, Rankl, Trance
Application Verdünnung: Lyophilized from a 0.22 µm filtered solution of PBS, pH 7.4 with 50 µg BSA per 1 µg as a carrier protein.
Anwendungsbeschreibung: Cross-Reactivity: Centrifuge the tube before opening. Reconstitute at 100 µg/mL in sterile PBS. For long term storage,please aliquot the reconstituted protein solution to minimize free-thaw cycles. , ResearchArea: Cytokines & Cytokine receptors
Recombinant Mouse TNFSF11/RANKL/CD254 Protein was determined by SDS-PAGE under reducing conditions with Coomassie Blue.